全球科技趋势报告系列：融合蛋白药物研发态势

随着重组 DNA 和蛋白质工程技术的快速发展，融合蛋白药物已经成为具有前景的生物技术产品。融合蛋白药物的药代动力学稳定性更高，对分子靶标的作用能力更强，还促进了新疫苗及基因和细胞治疗药物的开发，以应对未能解决的临床挑战。

Watch the webinar

Email address*

*First name

*Last name

*Organization Name

*Business phone

*Country or region

*State or Province

*City

*Job role

*Industry

Area of interest

*Please select one...

I wish to receive Updates and Announcements from CAS

I don’t wish to receive Updates, Announcements, and Research from CAS

address1

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Your privacy is important to CAS. More detail about how we use your information is in our privacy policy.